The influence of medication for Crohn's disease on serological response to the influenza vaccinatio

Phase 4

• Conditions: Crohn' s disease

• Registration Number: JPRN-UMIN000008043
• Lead Sponsor: The Jikei University School of Medicine Division of Gastroenterology and Hepatology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2012-05-28
• Study Completion: 2012-12-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Complete: follow-up complete
• Sex: All
• Target Recruitment: 150

Inclusion Criteria

Not provided

Exclusion Criteria

1)Patients who have been treated with Cyclosporin, Tacrolimus, Methotrexate, Steroids, total parental nutrition,granulocyte/monocyte apheresis therapy within 16 weeks. 2) Patients with severe infection or its complications within 1 year. 3) Patients with severe heart, kidney,liver,blood disease or developmental disorders. 4) Patients with allergic disease (Generalized rash etc.) 5) Patients with history of convulsion. 6) Patients diagnosed as an immune deficiency. 7) Patients with respiratory disease (interstitial pneumonia, bronchial asthma etc.) 8) Patients with allergy against ingredients of Influenza vaccine, hen's egg,or ingredients of hen. 9) Patients with drug or alcohol dependence or its history 10) Patients participated other clinical trial within 16 weeks. 11)Other patients judged as inappropriate bu the physician. 12) Patients received anti-TNF agents within 1 year (Only Elemental diet Groups) 13) Patients do not desire to receive Influenza vaccination.

Study & Design

• Study Type: Interventional
• Study Design: Not specified